Investigational Antibody GBR 1342 Receives Orphan Drug Designation for Multiple Myeloma
GBR 1342, an investigational bispecific antibody developed by Glenmark Pharmaceuticals, was granted orphan drug designation by the U.S Food and Drug Administration (FDA) for…